Big Pharma Co. Lobbies Against Legal Weed – So It Could Market Its Own Synthetic Version
Last year, backers of an Arizona initiative to legalize recreational marijuana ran into stiff resistance from a large pharmaceutical company. Opponents of Proposition 205 got a huge boost from drug company Insys Therapeutics in the form of a $500,000 donation. At the time, an Insys spokesperson said the company was opposing legalization because “it fails to protect the safety of Arizona’s citizens, and particularly its children.” However, the real reason, which was made official last week, was because Insys didn’t want competition. Insys’ new synthetic marijuana drug, Syndros, was given a green light by the FDA, as well as preliminary approval...
Read More